The information on this site is provided by CodeMap®. CodeMap® remains solely responsible for its content. The information provided is for general educational purposes only and may not be conclusive or exhaustive. Recent changes in applicable law, regulations and interpretations may not be reflected in the information contained herein. For technical questions, please contact CodeMap. This website is a private website and is not associated, endorsed or authorized by the Department of Health and Human Services, the Center for Medicare and Medicaid Services or any other public or government organization or agency. Healthcare-Associated Infections Enteric Infections Women's Health & Sexually-Transmitted Infections COVID-19 Point of Care Please select your state:NATIONAL LIMIT National Limits ALABAMA ALASKA ARIZONA ARKANSAS CALIFORNIA COLORADO CONNECTICUT DELAWARE DIST of COL-DC + MD/VA Suburbs FLORIDA GEORGIA HAWAII IDAHO ILLINOIS INDIANA IOWA KANSAS KENTUCKY LOUISIANA MAINE MARYLAND MASSACHUSETTS MICHIGAN MINNESOTA MISSISSIPPI MISSOURI MONTANA NATIONAL LIMIT NEBRASKA NEVADA NEW HAMPSHIRE NEW JERSEY NEW MEXICO NEW YORK NORTH CAROLINA NORTH DAKOTA OHIO OKLAHOMA OREGON PENNSYLVANIA PUERTO RICO RHODE ISLAND SOUTH CAROLINA SOUTH DAKOTA TENNESSEE TEXAS UTAH VERMONT VIRGINIA WASHINGTON WEST VIRGINIA WISCONSIN WYOMING Fees Reflect 2025 CMS Medicare Fee Schedules Fee schedules do not reflect 2% Payment Adjustment (Sequestration). Click here for more information. BD MAX™ SYSTEM Redefine staff productivity with a fully-integrated, automated molecular platform capable of running both IVD and open system assays efficiently and flexibly. BD MAX™ Enteric Panels CPT® Code Description Medicare Coverage NATIONAL LIMIT Medicare Reimbursement NATIONAL LIMIT Medicaid Reimbursement BD MAX™ Enteric Bacterial Panel: Includes 4 targets: Salmonella spp., Campylobacter spp. (jejuni / coli), Shigella spp., and Shiga-toxin producing E. coli (STEC)   87505 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets   CCI   MUE   $128.29 N/A BD MAX™ Extended Enteric Bacterial Panel: Includes 8 targets: 4 targets from the above BD MAX™ Enteric Bacterial Panel PLUS Vibrio (vulnuficus / parahaemolyticus / cholerae), Yersinia enterocolitica, Plesiomonas shigelloides, and Enterotoxigenic E. coli (ETEC)   87506 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 6-11 targets   CCI   MUE   $262.99 N/A BD MAX™ Enteric Parasite Panel: Includes 3 targets: Giardia lamblia, Cryptosporidium (parvum / hominis), and Entamoeba histolytica   87505 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets   CCI   MUE   $128.29 N/A BD MAX™ Enteric Viral Panel: Includes 5 targets: Norovirus (genogroups I and II), and Rotavirus A (subtypes 1-4), Adenovirus (F40/41), Sapovirus (genogroups I, II, IV, V), and Human Astrovirus (hAstro)   87505 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets   CCI   MUE   $128.29 N/A BD MAX™ Enteric Panel Combinations Panels Performed Total Targets CPT Code BD MAX™ Enteric Bacterial Panel + BD MAX™ Enteric Parasite Panel 7 87506 (6-11 targets) BD MAX™ Enteric Bacterial Panel + BD MAX™ Extended Enteric Bacterial Panel 8 87506 (6-11 targets) BD MAX™ Enteric Parasite Panel + BD MAX™ Enteric Viral Panel 8 87506 (6-11 targets) BD MAX™ Enteric Bacterial Panel + BD MAX™ Enteric Viral Panel 9 87506 (6-11 targets) BD MAX™ Enteric Bacterial Panel + BD MAX™ Extended Enteric Bacterial Panel + BD MAX™ Enteric Parasite Panel 11 87506 (6-11 targets) BD MAX™ Enteric Bacterial Panel + BD MAX™ Enteric Parasite Panel + BD MAX™ Enteric Viral Panel 12 87507 (12-25 targets) BD MAX™ Enteric Bacterial Panel + BD MAX™ Extended Enteric Bacterial Panel + BD MAX™ Enteric Viral Panel 13 87507 (12-25 targets) BD MAX™ Enteric Bacterial Panel + BD MAX™ Extended Enteric Bacterial Panel + BD MAX™ Enteric Parasite Panel + BD MAX™ Enteric Viral Panel 16 87507 (12-25 targets) CPT® Code Description Medicare Coverage NATIONAL LIMIT Medicare Reimbursement NATIONAL LIMIT Medicaid Reimbursement   87506 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 6-11 targets   CCI   MUE   $262.99 N/A   87507 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets   CCI   MUE   $416.78 N/A Becton, Dickinson and Company is not responsible for any actions taken by website users in billing Medicare for Becton, Dickinson and Company products, equipment or devices, including but not limited to, any billing and/or coding errors. Website users rely on the information contained in this website at their own risk and should check with the individual Medicare contractors to verify coverage, coding and payment. The information contained in this website has been compiled by CodeMap, L.L.C. to assist Becton, Dickinson and Company customers. CodeMap, L.L.C. remains solely responsible for its content. The information provided is for general educational purposes only and may not be conclusive or exhaustive. Recent changes in applicable law, regulations and interpretations may not be reflected in the information contained herein. For technical questions, please contact CodeMap at (847) 381-5465. CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this website. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors. No part of this web page or data displayed may be redistributed or used without the express written consent of CodeMap®. CPT copyright 2024 American Medical Association. All rights reserved. 02/05/2025 05:52:32 3.12.76.84